Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Yebeen Ysabelle Boo

Yebeen Ysabelle Boo

Yebeen Ysabelle Boo

BSc, MSc

DPhil Student

Ysabelle is a DPhil student at the National Perinatal Epidemiology Unit. Her DPhil project aims to develop an evidence-based, comprehensive facility-based stillbirth review process in India by conducting a mixed methods research, supervised by Dr Manisha Nair, Prof Jenny Kurinczuk and Prof Monica Lakhanpaul (UCL). Ysabelle's research is supported by the Clarendon Fund, Kellogg College Award, and a Nuffield Department of Population Health Scholarship. 

Ysabelle believes in promoting robust health systems and affordable, high-quality care to produce better health outcomes for all. Her research focuses on global maternal and child health and social determinants of health. Before starting her DPhil, Ysabelle studied BSc Population Health (data science pathway) at University College London (UCL), where she graduated with first class honours and was on the dean's list. She was awarded the Nuffield Department of Population Health bursary to study MSc in Global Health Science and Epidemiology from the University of Oxford, which she successfully completed in 2021. 

Professionally, Ysabelle worked as a senior consultant at Aceso Global Health Consultants, working for various UK and international projects. Academically, Ysabelle is a researcher for the Childhood Infections and Pollution (CHIP) consortium. This multi-country endeavour aims to address infections in children under-five living in peri-urban slums. It is currently being operationalised across four countries and is guided by the One Health technology-enabled citizen science approach reducing the infection burden and antimicrobial resistance.